DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 7Strides Pharma Science
03 1Acella Pharmaceuticals
04 13Actavis Inc
05 1Aeon Formulations Private Limited
06 4Ajanta Pharma Limited
07 11Alembic Pharmaceuticals Limited
08 5Amneal Pharmaceuticals
09 1Anwita Drugs
10 4Apotex Inc
11 1Aspiro Pharma
12 1Aurobindo Pharma Limited
13 7Avet Pharmaceuticals
14 2Bausch & Lomb Incorporated
15 2Bionpharma
16 3Cantabria Labs
17 2Changzhou Pharmaceutical Factory
18 9Chartwell Pharmaceuticals llc
19 1Delos Medica
20 1DenMat Dental
21 5Epic Pharma. LLC.
22 2Fresenius Kabi USA
23 1GALDERMA LABS LP
24 1GLAND PHARMA LIMITED
25 1Galderma
26 2HALSEY
27 3HEATHER
28 8Hikma Pharmaceuticals
29 1Holden Medical Laboratories Pvt. Ltd
30 3Hospira, Inc.
31 2Impax Laboratories
32 3Interpharm
33 2JAMP PHARMA
34 1Kindos Pharmaceuticals
35 1Kulzer Gmbh
36 1LABORATORIOS NORMON SA
37 1Laboratoire Riva
38 1Laboratorios Llorens Sa
39 1Llorens Laboratories Sl
40 11Lupin Ltd
41 1MANTRA PHARMA INC
42 2MS Pharma
43 2Macleods Pharmaceuticals Limited
44 10Mayne Pharma
45 3Mutual Pharmaceutical Company, Inc.
46 1Neopharma
47 2Nesher Pharmaceuticals USA LLC
48 1Novel Laboratories, Inc.
49 1ORYZA
50 1PH HEALTH
51 2PHARMOBEDIENT
52 1PRO DOC LIMITEE
53 2PVT FORM
54 1Pantex Holland
55 2Par Pharmaceutical
56 4Pelcoat Formulations
57 5Pfizer Inc
58 1Pharmaris
59 3Pharmascience Inc.
60 1Pliva Hrvatska
61 1Praxgen
62 1Precision Dose
63 3Prinston
64 2Qilu Animal Health Products
65 2Quad Pharma
66 1RACHELLE
67 7Rising Pharmaceuticals Inc
68 2SANIS HEALTH INC
69 1STERIMAX INC
70 3SUPERPHARM
71 2Shijiazhuang Fengqiang Animal Pharmaceutical Co., Ltd
72 2Slate Run Pharmaceuticals
73 1Steriscience
74 6Sun Pharmaceutical Industries Limited
75 1Teofarma
76 5Teva Pharmaceutical Industries
77 2Torrent Pharmaceuticals Limited
78 2Unichem Laboratories Limited
79 2V-Ensure
80 1VIC Group
81 2Viatris
82 1Virjo Healthcare
83 4Warner Chilcott Company, LLC
84 2West-ward Pharmaceutical Corp
85 2Zhejiang Yongtai Technology
86 3Zydus Lifesciences
87 5Zydus Pharmaceuticals
01 9CAPSULE
02 1CAPSULE, COATED PELLETS;ORAL
03 5CAPSULE, DELAYED RELEASE;ORAL
04 54CAPSULE;ORAL
05 7Capsule
06 1Capsule IP
07 1Coated Tablet
08 4Enteric Coated Pellets
09 5Hard Capsule
10 26INJECTABLE;INJECTION
11 1Inection
12 1Injectable And Infusion Solution
13 2Injectable; Injection
14 1Injection
15 1Oral Granule
16 1Oral Solution/Suspension
17 1Oral Suspension
18 1PELLET
19 1POWDER FOR SOLUTION
20 1Periodontal Gel
21 3Powder
22 1SYSTEM, EXTENDED RELEASE;PERIODONTAL
23 9TABLET
24 42TABLET, DELAYED RELEASE;ORAL
25 59TABLET;ORAL
26 2Tablet
27 1WSP / Premix
28 1Water Soluble Powder
01 8Authorized
02 3Cancelled
03 102DISCN
04 6Generic
05 16Prescription
06 86RX
07 21Blank
01 2ACTICLATE
02 1ACTICLATE CAP
03 1APO-DOXY CAP 100MG
04 1APO-DOXY TABS 100MG
05 1ATRIDOX
06 9DORYX
07 2DORYX MPC
08 1DOXIEONnn
09 1DOXY 100
10 1DOXY 200
11 3DOXY-LEMMON
12 1DOXYCHEL HYCLATE
13 1DOXYCIN TAB 100MG
14 7DOXYCYCLINE
15 1DOXYCYCLINE CAPSULES
16 1DOXYCYCLINE FOR INJECTION USP
17 154DOXYCYCLINE HYCLATE
18 1DOXYCYCLINE TABLETS
19 1DOXYTAB
20 1Dosil
21 1Dosil Enzymatic Capsules
22 1Doxiciclina Normon
23 1Doxidem 50
24 1Doxiten Bio
25 3Doxycycline Hyclate
26 1Doxyline-100
27 1Doxyline-200
28 1Doxyprem 100, 200
29 2Doxy®
30 1Gendox 10/5
31 1JAMP DOXYCYCLINE
32 1JAMP DOXYCYCLINE CAPSULES
33 1LYMEPAK
34 1Ligosan
35 1M-DOXYCYCLINE
36 1Neocycline
37 2PERIOSTAT
38 3PMS-DOXYCYCLINE
39 1PRZ-DOXYCYCLINE
40 3Proderma
41 2TEVA-DOXYCYCLINE
42 1VIBRA-TABS
43 4VIBRAMYCIN
44 2Vibracina
45 1Vibravenosa
46 13Blank
01 16Canada
02 4China
03 15India
04 2Jordan
05 1Netherlands
06 1Romania
07 1Russia
08 11Spain
09 1U.A.E
10 190USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2017-06-14
Application Number : 208765
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL
Packaging :
Approval Date : 2025-07-01
Application Number : 218753
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-03-29
Application Number : 62337
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1986-04-07
Application Number : 62538
Regulatory Info : DISCN
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : DOXYCYCLINE HYCLATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2025-11-24
Application Number : 62538
Regulatory Info : RX
Registration Country : USA
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Capsule
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info :
Registration Country : India
Brand Name : Doxycycline Hyclate
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ATRIDOX
Dosage Form : SYSTEM, EXTENDED RELEASE;PERIODONTAL
Dosage Strength : 50MG
Packaging :
Approval Date : 1998-09-03
Application Number : 50751
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1998-09-30
Application Number : 50744
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PERIOSTAT
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2001-02-02
Application Number : 50783
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1985-07-22
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DORYX
Dosage Form : CAPSULE, DELAYED RELEASE;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2001-08-13
Application Number : 50582
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 50007
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 200MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRAMYCIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 100MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50442
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : VIBRA-TABS
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1982-01-01
Application Number : 50533
Regulatory Info : DISCN
Registration Country : USA
